About The Study: The results of this study of more than 20,000 men with low-risk prostate cancer suggest that active surveillance rates are rising nationally but are still suboptimal, and wide variation persists across practices and practitioners. Continued progress on this critical quality indicator is essential to minimize overtreatment of low-risk prostate cancer and by extension to improve the benefit-to-harm ratio of national prostate cancer early detection efforts.
Authors: Matthew R. Cooperberg, M.D., M.P.H., of the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.1439?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=030223
JAMA Network Open